Company Update: Abbott Laboratories (NYSE:ABT) – Abbott Completes Acquisition of CFR Pharmaceuticals; Announces Results of Tender Offer for CFR Shares

[PR Newswire] – ABBOTT PARK, Ill., Sept. 26, 2014 /PRNewswire/ — Abbott (ABT) has acquired control of CFR Pharmaceuticals, more than doubling its Latin American branded generics pharmaceutical presence and further expanding the . . . → Read More: Company Update: Abbott Laboratories (NYSE:ABT) – Abbott Completes Acquisition of CFR Pharmaceuticals; Announces Results of Tender Offer for CFR Shares Similar Articles: Market Update (NYSE:ABT): Abbott to Showcase Innovations to Help Labs Solve Health Care Challenges at the American Association for Clinical Chemistry Lab Expo Company Update (NASDAQ:AAPL): Lassonde Industries Inc. completes acquisition of Apple & Eve, LLC of Port… Company Update (NYSE:GE): Leading forensic laboratories participate in independent validation of the GE Healthcare Life Sciences and NetBio Rapid DNA system